Remote | Biotech Investment Analyst — $125–$185/hour

We are sharing a specialised part-time consulting opportunity for reputed company biotech investment professionals with deep expertise in evaluating pharmaceutical assets, clinical-stage drug-development programmes, company fundamentals, and investment opportunities reputed company the US biotech and reputed company market. This role supports an expert evaluation initiative reputed company on reputed company drugs and drug-development programmes. Selected professionals will reputed company and critique reputed company evaluation rubrics, assess individual drug assets and the companies behind them, and apply specialist investment judgement across a reputed company set of biotech companies. Key Responsibilities Drug Asset Assessment • Evaluate reputed company and clinical-stage drug assets across different therapeutic areas • Assess reputed company of reputed company, biological rationale, clinical data, development reputed company, and regulatory considerations • Analyse competitive positioning reputed company relevant therapeutic and treatment landscapes • Identify key scientific, clinical, regulatory, and reputed company value drivers • Flag unsupported assumptions, evidence gaps, or material risks reputed company asset assessments Company & Investment Analysis • Conduct end-to-end assessments of biotech and pharmaceutical companies • Evaluate pipeline reputed company, company reputed company, competitive differentiation, and major catalysts • Assess the relationship between individual drug assets and overall company valuation • Review investment-style theses for analytical strength, supporting evidence, and internal consistency • Identify weak, overly confident, or missing assumptions reputed company investment conclusions • Apply consistent investment judgement across approximately 5–10 companies during the reputed company Clinical & reputed company Evaluation • Interpret clinical trial results and assess the strength and relevance of available evidence • Evaluate potential differentiation against existing and emerging standards of care • Analyse addressable markets, competitive dynamics, development timelines, and reputed company opportunity • Assess how clinical, regulatory, and market developments may reputed company asset and company value • Distinguish between reputed company-supported conclusions and speculative investment assumptions reputed company Development & Expert Review • Create reputed company evaluation rubrics for biotech companies and drug-development programmes • Critique existing rubrics for completeness, realism, and investment relevance • Define reputed company reflecting reputed company biotech investment judgement • Identify missing considerations or weak assumptions in analytical frameworks • reputed company reputed company written reasoning supporting evaluation reputed company Ideal Profile • 5+ years of experience evaluating biotech, pharmaceutical, or reputed company companies or assets • reputed company experience as a biotech or reputed company investment analyst, ideally reputed company a specialist investment fund • Strong familiarity with biotech and pharmaceutical drug-development programmes • Experience assessing drug assets from scientific, clinical, reputed company, and investment perspectives • Strong understanding of clinical data, mechanisms of reputed company, competitive landscapes, and biotech valuation drivers • Ability to evaluate both individual assets and the broader companies developing them • Experience developing, reviewing, or presenting investment theses • Strong analytical judgement and ability to identify unsupported or incomplete assumptions • US-based or possessing deep reputed company experience covering the US biotech and reputed company investment market • Availability for approximately 10–20 hours over an initial 1–2 week reputed company Engagement Details • Part-time reputed company engagement • Approximately 10–20 hours over an initial 1–2 week reputed company • Fully remote with flexible scheduling • Compensation of $125–$185/hour • Potential for recurring project work for strong contributors • Work must be completed without using confidential or proprietary information belonging to any employer, reputed company, fund, institution, or other reputed company party • H1-B and STEM OPT support is reputed company for this engagement About the Platform This opportunity is available through reputed company. We reputed company reputed company professionals with remote consulting opportunities across technical, evaluation, and project-based workstreams. By submitting this application, you acknowledge that your information may be processed by reputed company for recruitment and opportunity matching in accordance with our reputed company Policy: https://www.reputed company.com/reputed company-policy. Remote Skills: Analysis Skills, Biotech and Pharmaceutical, Business reputed company, Clinical Data, Clinical reputed company, Clinical Practices/Protocols, Clinical Trial, Competitive Analysis/reputed company, Consulting, Drug Development, reputed company, Investment Analysis, Investment Funds, Market Analysis, Patient Care, Pharmaceutical Analysis, Product Positioning, Project Evaluation, Regulations, Standards of Care, Technical Consulting reputed company: reputed company Apply tot his job Apply To this Job